Chair and Department of Palliative Medicine, Poznan University of Medical Sciences, Osiedle Rusa 25 A, 61-245, Poznan, Poland.
Curr Pain Headache Rep. 2011 Aug;15(4):271-9. doi: 10.1007/s11916-011-0201-7.
Cancer pain is generally treated with pharmacological measures, relying on using opioids alone or in combination with adjuvant analgesics. Weak opioids are used for mild-to-moderate pain as monotherapy or in a combination with nonopioids. For patients with moderate-to-severe pain, strong opioids are recommended as initial therapy rather than beginning treatment with weak opioids. Adjunctive therapy plays an important role in the treatment of cancer pain not fully responsive to opioids administered alone (ie, neuropathic, bone, and visceral colicky pain). Supportive drugs should be used wisely to prevent and treat opioids' adverse effects. Understanding the pharmacokinetics, pharmacodynamics, interactions, and cautions with commonly used opioids can help determine appropriate opioid selection for individual cancer patients.
癌症疼痛一般采用药物治疗措施,依靠单独使用阿片类药物或联合辅助镇痛药物。弱阿片类药物用于轻度至中度疼痛的单药治疗或与非阿片类药物联合使用。对于中重度疼痛患者,建议将强阿片类药物作为初始治疗药物,而不是开始使用弱阿片类药物。辅助治疗在单独使用阿片类药物治疗效果不佳的癌症疼痛(即神经病理性、骨痛和内脏绞痛)的治疗中起着重要作用。应明智地使用支持性药物来预防和治疗阿片类药物的不良反应。了解常用阿片类药物的药代动力学、药效学、相互作用和注意事项有助于确定个体癌症患者的合适阿片类药物选择。